← 產業報告目錄

Peptide Cosmetic API Research Report by Application (Anti-Aging & Wrinkle Reduction, Skin Repair & Regeneration, Moisturizing & Hydration, Whitening & Brightening, Hair Care, Anti-Inflammatory & Soothing), by Source (Plant-Derived Peptides, Animal-Derived Peptides, Bioengineered Peptides, Chemically Synthesized), by End-Use Industry (Skincare, Haircare, Injectable Cosmetics, Others), by Region (North America, Europe, APAC, South America, MEA) Forecast till 2035

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2025-06-15頁數 169報告編號 MRFRHC38117HCR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

Peptide Cosmetic API Research Report by Application (Anti-Aging & Wrinkle Reduction, Skin Repair & Regeneration, Moisturizing & Hydration, Whitening & Brightening, Hair Care, Anti-Inflammatory & Soothing), by Source (Plant-Derived Peptides, Animal-Derived Peptides, Bioengineered Peptides, Chemically Synthesized), by End-Use Industry (Skincare, Haircare, Injectable Cosmetics, Others), by Region (North America, Europe, APAC, South America, MEA) Forecast till 2035 Market Overview Global peptide cosmetic API market generated USD 921.3 million in revenue in 2024 and expected to achieve USD 2,968.4 million by 2035 at a CAGR of 11.2%. Global peptide cosmetic API market is being significantly driven by the rising demand for natural and organic cosmetic products, as consumers increasingly seek safer and more skin-friendly alternatives. Technological advancements in peptide synthesis have further propelled market growth, enabling the development of more stable and effective formulations. Additionally, the growing trend toward personalized skincare has heightened the appeal of peptides, which can be tailored to target specific skin concerns. Ongoing research highlighting the dermatological benefits of peptides continues to support their widespread adoption in cosmetic applications. However, the market faces several restraints, including the high cost of peptide synthesis and formulation, challenges in stability and effective delivery, and stringent regulatory requirements that often lead to approval delays. Furthermore, the presence of alternative active ingredients adds to competitive pressures. Despite these challenges, the global market presents strong opportunities, particularly in areas like bioengineered peptides for clean beauty, AI-powered skincare personalization, men's grooming with anti-aging solutions, multi-step skincare innovations, and innovations in peptide research. Market Segmentations By application category, the Global peptide cosmetic API market is divided into anti-aging & wrinkle reduction, skin repair & regeneration, moisturizing & hydration, whitening & brightening, hair care, anti-inflammatory & soothing. Based on the source type, the global market is included plant-derived peptides, animal-derived peptides, bioengineered peptides, chemically synthesized. Skincare, haircare, injectable cosmetics, and others are the part of end-use type of the global peptide cosmetic API market. Regional Insights North America dominates global peptide cosmetic API market owing to strong consumer awareness, a solid base of established cosmetic companies, and rising demand for advanced anti-aging and functional skincare products. The presence of leading R&D centers and an inclination toward premium, scientifically backed formulas further supports market leadership. Europe is close behind, driven by the clean beauty movement, stringent safety regulations, and a well-developed anti-aging segment in markets like France, the UK, and Germany. Asia-Pacific exhibits the fastest expansion, fueled by increasing skincare awareness, influence from K-beauty and J-beauty trends, and accelerating urbanization in key nations like China, Japan, and South Korea. Consumers here are drawn to multifunctional, innovative cosmetics. Latin America, especially Brazil, is steadily rising due to growing interest in natural and age-defying formulations. The Middle East & Africa region is showing gradual development, primarily supported by urban areas and a rise in disposable income levels. Major Players Major players of global peptide cosmetic API research report are Ashland Global Holdings, Symrise AG, Spec-Chem Industry Inc, Chemisches Laboratorium Dr. Kurt Richter GmbH, DSM-Firmenich, Provital Group, Bachem, Lipotrue Science, Croda, Caregen, BASF SE, Evonik Industries AG, Givaudan Active Beauty, Ambiopharm, Lipotec, USV Private Limited, Active Peptide Company, Seiwa Kasei Co. Ltd., RS Synthesis, BCN Peptides.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY .......................................... 21 2 MARKET INTRODUCTION ...................................... 23 2.1 DEFINITION .................... 23 2.2 SCOPE OF THE STUDY ....................................................................... 23 2.3 RESEARCH OBJECTIVE ..................................................................... 23 2.4 MARKET STRUCTURE ....................................................................... 24 3 RESEARCH METHODOLOGY ................................. 26 3.1 OVERVIEW ...................... 26 3.2 DATA FLOW .................... 28 3.2.1 DATA MINING PROCESS ................................................................ 28 3.3 PURCHASED DATABASE: .................................................................. 29 3.4 SECONDARY SOURCES: ..................................................................... 30 3.4.1 SECONDARY RESEARCH DATA FLOW: ................................................ 31 3.5 PRIMARY RESEARCH: ........................................................................ 32 3.5.1 PRIMARY RESEARCH DATA FLOW: ................................................ 33 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED .................. 34 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ....................................... 34 3.6 APPROACHES FOR MARKET END USER ESTIMATION: ........ 35 3.6.1 REVENUE ANALYSIS APPROACH ..................................................... 35 3.6.2 DATA FORECASTING ...................................................................... 36 3.6.3 DATA FORECASTING TECHNIQUE ..................................................... 36 3.7 DATA MODELING .......... 37 3.7.1 MICROECONOMIC FACTOR ANALYSIS: ................................................ 37 3.7.2 DATA MODELING: ........................................................................ 38 3.8 TEAMS AND ANALYST CONTRIBUTION .................................... 39 4 MARKET DYNAMICS ............................................... 41 4.1 INTRODUCTION ............. 41 4.2 DRIVERS ........................... 42 4.2.1 INCREASING DEMAND FOR NATURAL AND ORGANIC COSMETICS ............. 42 4.2.2 TECHNOLOGICAL ADVANCEMENTS IN PEPTIDE SYNTHESIS ................... 42 4.2.3 GROWING PREFERENCE FOR PERSONALIZED SKINCARE SOLUTIONS ........... 43 4.2.4 EXPANDING RESEARCH ON PEPTIDE BENEFITS IN DERMATOLOGY ........... 43 4.3 RESTRAINTS .................. 43 4.3.1 HIGH COST OF PEPTIDE SYNTHESIS AND FORMULATION ....................... 43 4.3.2 STABILITY AND DELIVERY CHALLENGES .............................................. 44 4.3.3 REGULATORY COMPLEXITIES AND APPROVAL DELAYS ........................... 44 4.3.4 COMPETITION FROM ALTERNATIVE ACTIVE INGREDIENTS........................ 44 4.4 OPPORTUNITY ............... 45 4.4.1 BIOENGINEERED PEPTIDES IN CLEAN BEAUTY ................................... 45 4.4.2 AI-DRIVEN PERSONALIZED SKINCARE ............................................... 45 4.4.3 PEPTIDES IN MULTI-STEP SKINCARE REGIMENS................................. 45 4.4.4 MEN'S GROOMING AND ANTI-AGING SOLUTIONS ................................. 46 4.4.5 INNOVATIONS IN PEPTIDE RESEARCH ............................................... 46 4.5 IMPACT ANALYSIS OF COVID – 19 ................................................ 47 4.5.1 IMPACT 0N OVERALL HEALTHCARE. .............................................. 47 4.5.2 ECONOMIC IMPACT. ................................................................ 47 4.5.3 IMPACT ON GLOBAL PEPTIDE COSMETIC API MARKET MARKET. ... 48 4.5.4 IMPACT ON SUPPLY CHAIN OF PEPTIDE COSMETIC API MARKET..... 48 4.5.5 PRICE VARIATION OF KEY RAW MATERIALS. ............................ 48 4.5.6 PRODUCTION SHUTDOWN. ...................................................... 49 4.5.7 CASH FLOW CONSTRAINTS. .................................................... 49 4.5.8 IMPACT ON IMPORT/EXPORT. ................................................. 49 4.5.9 IMPACT ON MARKET DEMAND OF PEPTIDE COSMETIC API MARKET. ...................................................................... 50 4.5.10 IMPACT DUE TO RESTRICTIONS/LOCKDOWN. ........................... 50 4.5.11 CONSUMER SENTIMENTS. ....................................................... 50 4.5.12 IMPACT ON PRICING OF PEPTIDE COSMETIC API MARKET. ............ 51 5 MARKET FACTOR ANALYSIS ................................. 52 5.1 SUPPLY CHAIN ANALYSIS .............................................................. 52 5.1.1 RAW MATERIAL PROCUREMENT .............................................. 53 5.1.2 MANUFACTURING & SYNTHESIS .............................................. 53 5.1.3 PACKAGING AND STORAGE ..................................................... 54 5.1.4 DISTRIBUTION & LOGISTICS ..................................................... 54 5.1.5 END-USERS & CONSUMER DELIVERY ........................................ 54 5.2 PORTER’S FIVE FORCES MODEL .................................................... 55 5.2.1 BARGAINING POWER OF SUPPLIERS .................................................. 55 5.2.2 BARGAINING POWER OF BUYERS ..................................................... 56 5.2.3 THREAT OF NEW ENTRANTS ............................................................ 56 5.2.4 THREAT OF SUBSTITUTES ............................................................... 56 5.2.5 INTENSITY OF RIVALRY ................................................................... 57 6 PEPTIDE COSMETIC API MARKET, BY APPLICATION .............................................................. 59 6.1 INTRODUCTION ............. 59 6.2 ANTI-AGING & WRINKLE REDUCTION ........................................ 59 6.3 SKIN REPAIR & REGENERATION ................................................... 60 6.4 MOISTURIZING & HYDRATION ....................................................... 60 6.5 WHITENING & BRIGHTENING ......................................................... 60 6.6 HAIR CARE ...................... 61 6.7 ANTI-INFLAMMATORY & SOOTHING .......................................... 61 7 PEPTIDE COSMETIC API MARKET, BY SOURCE . 62 7.1 INTRODUCTION ............. 62 7.2 PLANT-DERIVED PEPTIDES ............................................................ 62 7.3 ANIMAL-DERIVED PEPTIDES ......................................................... 62 7.4 BIOENGINEERED PEPTIDES ............................................................. 63 7.5 CHEMICALLY SYNTHESIZED .......................................................... 63 8 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY.................................................... 64 8.1 INTRODUCTION ............. 64 8.2 SKINCARE ....................... 64 8.3 HAIRCARE ....................... 64 8.4 INJECTABLE COSMETICS ................................................................. 65 8.5 OTHERS ............................ 65 9 PEPTIDE COSMETIC API MARKET, BY REGION .. 66 9.1 OVERVIEW ...................... 66 9.2 NORTH AMERICA ......... 67 9.2.1 US.................... 68 9.2.2 CANADA ............ 69 9.3 EUROPE ............................ 70 9.3.1 GERMANY .......... 71 9.3.2 UK ................... 73 9.3.3 FRANCE ........... 74 9.3.4 RUSSIA ............ 75 9.3.5 ITALY ............... 76 9.3.6 SPAIN .............. 77 9.3.7 REST OF EUROPE ..................................................................... 78 9.4 APAC ................................. 79 9.4.1 CHINA ............... 80 9.4.2 INDIA ............... 81 9.4.3 JAPAN ............. 82 9.4.4 SOUTH KOREA .. 83 9.4.5 MALAYSIA ....... 84 9.4.6 THAILAND ........ 85 9.4.7 INDONESIA ....... 86 9.4.8 REST OF APAC ........................................................................ 87 9.5 SOUTH AMERICA ......... 88 9.5.1 BRAZIL ............... 89 9.5.2 MEXICO ........... 91 9.5.3 ARGENTINA ..... 92 9.5.4 REST OF SOUTH AMERICA ....................................................... 93 9.6 MEA ................................... 94 9.6.1 GCC COUNTRIES .. 95 9.6.2 SOUTH AFRICA ..... 96 9.6.3 REST OF MEA ..... 97 10 COMPETITIVE LANDSCAPE ................................... 99 10.1 INTRODUCTION ............. 99 10.2 MARKET SHARE ANALYSIS, 2023 ................................................ 99 10.3 COMPETITOR DASHBOARD.............................................................. 101 11 COMPANY PROFILES ............................................. 102 11.1 DSM-FIRMENICH .......... 102 11.1.1 COMPANY OVERVIEW .............................................................. 102 11.1.2 FINANCIAL OVERVIEW.............................................................. 103 11.1.3 TYPES OFFERED ...................................................................... 103 11.1.4 PATENT DETAILS ... 104 11.1.5 PRODUCTION CAPACITY ................................................................ 104 11.1.6 SALES VOLUME ... 104 11.1.7 PRICING ANALYSIS ....................................................................... 105 11.1.8 SWOT ANALYSIS ..................................................................... 105 11.1.9 KEY STRATEGY ..... 106 11.2 BACHEM .......................... 107 11.2.1 COMPANY OVERVIEW .............................................................. 107 11.2.2 FINANCIAL OVERVIEW.............................................................. 108 11.2.3 TYPES OFFERED ...................................................................... 108 11.2.4 PATENT DETAILS ... 109 11.2.5 PRODUCTION CAPACITY ................................................................ 109 11.2.6 SALES VOLUME ... 109 11.2.7 PRICING ANALYSIS ....................................................................... 109 11.2.8 SWOT ANALYSIS ..................................................................... 110 11.2.9 KEY STRATEGY ..... 110 11.3 LIPOTRUE SCIENCE ..... 111 11.3.1 COMPANY OVERVIEW .............................................................. 111 11.3.2 TYPES OFFERED ...................................................................... 111 11.3.3 PATENT DETAILS ... 111 11.3.4 PRODUCTION CAPACITY ................................................................ 112 11.3.5 SALES VOLUME ... 112 11.3.6 PRICING ANALYSIS ....................................................................... 112 11.3.7 SWOT ANALYSIS ..................................................................... 113 11.3.8 KEY STRATEGY ..... 113 11.4 CRODA ............................... 114 11.4.1 COMPANY OVERVIEW .............................................................. 114 11.4.2 FINANCIAL OVERVIEW.............................................................. 115 11.4.3 TYPES OFFERED ...................................................................... 115 11.4.4 PATENT DETAILS ... 116 11.4.5 PRODUCTION CAPACITY ................................................................ 116 11.4.6 SALES VOLUME ... 116 11.4.7 PRICING ANALYSIS ....................................................................... 116 11.4.8 SWOT ANALYSIS ..................................................................... 117 11.4.9 KEY STRATEGY ..... 117 11.5 CAREGEN ......................... 118 11.5.1 COMPANY OVERVIEW .............................................................. 118 11.5.2 TYPES OFFERED ...................................................................... 118 11.5.3 PATENT DETAILS ... 118 11.5.4 PRODUCTION CAPACITY ................................................................ 119 11.5.5 SALES VOLUME ... 119 11.5.6 PRICING ANALYSIS ....................................................................... 119 11.5.7 SWOT ANALYSIS ..................................................................... 120 11.5.8 KEY STRATEGY ..... 120 11.6 BASF SE ............................ 121 11.6.1 COMPANY OVERVIEW .............................................................. 121 11.6.2 FINANCIAL OVERVIEW.............................................................. 121 11.6.3 TYPES OFFERED ...................................................................... 122 11.6.4 PATENT DETAILS ... 122 11.6.5 PRODUCTION CAPACITY ................................................................ 122 11.6.6 SALES VOLUME ... 123 11.6.7 PRICING ANALYSIS ....................................................................... 123 11.6.8 SWOT ANALYSIS ..................................................................... 123 11.6.9 KEY STRATEGY ..... 124 11.7 EVONIK INDUSTRIES AG .................................................................. 125 11.7.1 COMPANY OVERVIEW ............................................................. 125 11.7.2 FINANCIAL OVERVIEW.............................................................. 126 11.7.3 TYPES OFFERED ...................................................................... 126 11.7.4 PATENT DETAILS ... 127 11.7.5 PRODUCTION CAPACITY ................................................................ 127 11.7.6 SALES VOLUME ... 127 11.7.7 PRICING ANALYSIS ....................................................................... 127 11.7.8 SWOT ANALYSIS ..................................................................... 128 11.7.9 KEY STRATEGY ..... 128 11.8 GIVAUDAN ACTIVE BEAUTY .......................................................... 129 11.8.1 COMPANY OVERVIEW ............................................................. 129 11.8.2 FINANCIAL OVERVIEW.............................................................. 129 11.8.3 TYPES OFFERED ...................................................................... 130 11.8.4 PATENT DETAILS ... 130 11.8.5 PRODUCTION CAPACITY ................................................................ 130 11.8.6 SALES VOLUME ... 130 11.8.7 PRICING ANALYSIS ....................................................................... 131 11.8.8 SWOT ANALYSIS ..................................................................... 131 11.8.9 KEY STRATEGY ..... 132 11.9 ASHLAND GLOBAL HOLDINGS ........................................................ 133 11.9.1 COMPANY OVERVIEW .............................................................. 133 11.9.2 FINANCIAL OVERVIEW.............................................................. 133 11.9.3 TYPES OFFERED ...................................................................... 134 11.9.4 PATENT DETAILS ... 134 11.9.5 PRODUCTION CAPACITY ................................................................ 134 11.9.6 SALES VOLUME ... 134 11.9.7 PRICING ANALYSIS ....................................................................... 135 11.9.8 SWOT ANALYSIS ..................................................................... 135 11.9.9 KEY STRATEGY ..... 135 11.10 SYMRISE AG ................... 136 11.10.1 COMPANY OVERVIEW .............................................................. 136 11.10.2 FINANCIAL OVERVIEW.............................................................. 136 11.10.3 TYPES OFFERED ...................................................................... 137 11.10.4 PATENT DETAILS ... 137 11.10.5 PRODUCTION CAPACITY ................................................................ 137 11.10.6 SALES VOLUME ... 137 11.10.7 PRICING ANALYSIS ....................................................................... 137 11.10.8 SWOT ANALYSIS ..................................................................... 138 11.10.9 KEY STRATEGY ..... 138 11.11 PROVITAL GROUP ........ 139 11.11.1 COMPANY OVERVIEW .............................................................. 139 11.11.2 TYPES OFFERED ...................................................................... 139 11.11.3 PATENT DETAILS ... 139 11.11.4 PRODUCTION CAPACITY ................................................................ 140 11.11.5 SALES VOLUME ... 140 11.11.6 PRICING ANALYSIS ....................................................................... 140 11.11.7 SWOT ANALYSIS ..................................................................... 141 11.11.8 KEY STRATEGY ..... 141 11.12 SPEC-CHEM INDUSTRY INC ............................................................ 142 11.12.1 COMPANY OVERVIEW .............................................................. 142 11.12.2 TYPES OFFERED ...................................................................... 142 11.12.3 PATENT DETAILS ... 142 11.12.4 PRODUCTION CAPACITY ................................................................ 143 11.12.5 SALES VOLUME ... 143 11.12.6 PRICING ANALYSIS ....................................................................... 143 11.12.7 SWOT ANALYSIS ..................................................................... 144 11.12.8 KEY STRATEGY ..... 144 11.13 AMBIOPHARM ............... 145 11.13.1 COMPANY OVERVIEW .............................................................. 145 11.13.2 TYPES OFFERED ...................................................................... 145 11.13.3 PATENT DETAILS ... 145 11.13.4 PRODUCTION CAPACITY ................................................................ 146 11.13.5 SALES VOLUME ... 146 11.13.6 PRICING ANALYSIS ....................................................................... 146 11.13.7 SWOT ANALYSIS ..................................................................... 147 11.13.8 KEY STRATEGY ..... 147 11.14 LIPOTEC ........................... 148 11.14.1 COMPANY OVERVIEW ............................................................. 148 11.14.2 TYPES OFFERED ...................................................................... 148 11.14.3 PATENT DETAILS ... 148 11.14.4 PRODUCTION CAPACITY ................................................................ 149 11.14.5 SALES VOLUME ... 149 11.14.6 PRICING ANALYSIS ....................................................................... 149 11.14.7 SWOT ANALYSIS ..................................................................... 150 11.14.8 KEY STRATEGY ..... 150 11.15 USV PRIVATE LIMITED ..................................................................... 151 11.15.1 COMPANY OVERVIEW ............................................................. 151 11.15.2 TYPES OFFERED ...................................................................... 151 11.15.3 PATENT DETAILS ... 151 11.15.4 PRODUCTION CAPACITY ................................................................ 152 11.15.5 SALES VOLUME ... 152 11.15.6 PRICING ANALYSIS ....................................................................... 152 11.15.7 SWOT ANALYSIS ..................................................................... 153 11.15.8 KEY STRATEGY ..... 153 11.16 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR) ........................................................... 154 11.16.1 COMPANY OVERVIEW .............................................................. 154 11.16.2 TYPES OFFERED ...................................................................... 154 11.16.3 PATENT DETAILS ... 154 11.16.4 PRODUCTION CAPACITY ................................................................ 155 11.16.5 SALES VOLUME ... 155 11.16.6 PRICING ANALYSIS ....................................................................... 155 11.16.7 SWOT ANALYSIS ..................................................................... 156 11.16.8 KEY STRATEGY ..... 156 11.17 ACTIVE PEPTIDE COMPANY ........................................................... 157 11.17.1 COMPANY OVERVIEW .............................................................. 157 11.17.2 TYPES OFFERED ...................................................................... 157 11.17.3 PATENT DETAILS ... 158 11.17.4 PRODUCTION CAPACITY ................................................................ 158 11.17.5 SALES VOLUME ... 158 11.17.6 PRICING ANALYSIS ....................................................................... 158 11.17.7 SWOT ANALYSIS ..................................................................... 159 11.17.8 KEY STRATEGY ..... 159 11.18 SEIWA KASEI CO., LTD ....................................................................... 160 11.18.1 COMPANY OVERVIEW ............................................................. 160 11.18.2 TYPES OFFERED ...................................................................... 160 11.18.3 PATENT DETAILS ... 160 11.18.4 PRODUCTION CAPACITY ................................................................ 161 11.18.5 SALES VOLUME ... 161 11.18.6 PRICING ANALYSIS ....................................................................... 161 11.18.7 SWOT ANALYSIS ..................................................................... 162 11.18.8 KEY STRATEGY ..... 162 11.19 RS SYNTHESIS ............... 163 11.19.1 COMPANY OVERVIEW .............................................................. 163 11.19.2 TYPES OFFERED ...................................................................... 163 11.19.3 PATENT DETAILS ... 163 11.19.4 PRODUCTION CAPACITY ................................................................ 164 11.19.5 SALES VOLUME ... 164 11.19.6 PRICING ANALYSIS ....................................................................... 164 11.19.7 SWOT ANALYSIS ..................................................................... 165 11.19.8 KEY STRATEGY ..... 165 11.20 BCN PEPTIDES ............... 166 11.20.1 COMPANY OVERVIEW .............................................................. 166 11.20.2 TYPES OFFERED ...................................................................... 166 11.20.3 PATENT DETAILS ... 166 11.20.4 PRODUCTION CAPACITY ................................................................ 167 11.20.5 SALES VOLUME ... 167 11.20.6 PRICING ANALYSIS ....................................................................... 167 11.20.7 SWOT ANALYSIS ..................................................................... 168 11.20.8 KEY STRATEGY ............................................................................ 168
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 59 TABLE 2 PEPTIDE COSMETIC API MARKET, SOURCE, 2019-2035 (USD MILLION) 62 TABLE 3 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 64 TABLE 4 PEPTIDE COSMETIC API MARKET, BY REGION, 2019-2035 (USD MILLION) 66 TABLE 5 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY COUNTRY, 2019-2035 (USD MILLION) 67 TABLE 6 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY APPLICATION, 2019-2035 (USD MILLION) 67 TABLE 7 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY SOURCE, 2019-2035 (USD MILLION) 67 TABLE 8 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 68 TABLE 9 US: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 68 TABLE 10 US: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 68 TABLE 11 US: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 69 TABLE 12 CANADA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 69 TABLE 13 CANADA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 69 TABLE 14 CANADA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 70 TABLE 15 PEPTIDE COSMETIC API MARKET, FOR EUROPE, BY COUNTRY, 2019-2035 (USD MILLION) 70 TABLE 16 PEPTIDE COSMETIC API MARKET, FOR EUROPE , BY APPLICATION, 2019-2035 (USD MILLION) 70 TABLE 17 PEPTIDE COSMETIC API MARKET, FOR EUROPE, BY SOURCE, 2019-2035 (USD MILLION) 71 TABLE 18 PEPTIDE COSMETIC API MARKET, FOR EUROPE , BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 71 TABLE 19 GERMANY: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 71 TABLE 20 GERMANY: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 72 TABLE 21 GERMANY: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 72 TABLE 22 UK: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 73 TABLE 23 UK: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 73 TABLE 24 UK: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 73 TABLE 25 FRANCE: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 74 TABLE 26 FRANCE: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 74 TABLE 27 FRANCE: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 74 TABLE 28 RUSSIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 75 TABLE 29 RUSSIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 75 TABLE 30 RUSSIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 75 TABLE 31 ITALY: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 76 TABLE 32 ITALY: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 76 TABLE 33 ITALY: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 76 TABLE 34 SPAIN: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 77 TABLE 35 SPAIN: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 77 TABLE 36 SPAIN: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 77 TABLE 37 REST OF EUROPE: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 78 TABLE 38 REST OF EUROPE: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 78 TABLE 39 REST OF EUROPE: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 78 TABLE 40 PEPTIDE COSMETIC API MARKET, FOR APAC , BY COUNTRY, 2019-2035 (USD MILLION) 79 TABLE 41 PEPTIDE COSMETIC API MARKET, FOR APAC , BY APPLICATION, 2019-2035 (USD MILLION) 79 TABLE 42 PEPTIDE COSMETIC API MARKET, FOR APAC , BY SOURCE, 2019-2035 (USD MILLION) 79 TABLE 43 PEPTIDE COSMETIC API MARKET, FOR APAC , BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 80 TABLE 44 CHINA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 80 TABLE 45 CHINA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 80 TABLE 46 CHINA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 81 TABLE 47 INDIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 81 TABLE 48 INDIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 81 TABLE 49 INDIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 82 TABLE 50 JAPAN: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 82 TABLE 51 JAPAN: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 82 TABLE 52 JAPAN: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 83 TABLE 53 SOUTH KOREA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 83 TABLE 54 SOUTH KOREA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 83 TABLE 55 SOUTH KOREA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 84 TABLE 56 MALAYSIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 84 TABLE 57 MALAYSIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 84 TABLE 58 MALAYSIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 85 TABLE 59 THAILAND: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 85 TABLE 60 THAILAND: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 85 TABLE 61 THAILAND: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 86 TABLE 62 INDONESIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 86 TABLE 63 INDONESIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 86 TABLE 64 INDONESIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 87 TABLE 65 REST OF APAC: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 87 TABLE 66 REST OF APAC: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 87 TABLE 67 REST OF APAC: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 88 TABLE 68 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY COUNTRY, 2019-2035 (USD MILLION) 88 TABLE 69 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY APPLICATION, 2019-2035 (USD MILLION) 88 TABLE 70 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY SOURCE, 2019-2035 (USD MILLION) 89 TABLE 71 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 89 TABLE 72 BRAZIL: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 89 TABLE 73 BRAZIL: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 90 TABLE 74 BRAZIL: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 90 TABLE 75 MEXICO: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 91 TABLE 76 MEXICO: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 91 TABLE 77 MEXICO: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 91 TABLE 78 ARGENTINA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 92 TABLE 79 ARGENTINA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 92 TABLE 80 ARGENTINA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 92 TABLE 81 REST OF SOUTH AMERICA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 93 TABLE 82 REST OF SOUTH AMERICA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 93 TABLE 83 REST OF SOUTH AMERICA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 93 TABLE 84 PEPTIDE COSMETIC API MARKET, FOR MEA, BY COUNTRY, 2019-2035 (USD MILLION) 94 TABLE 85 PEPTIDE COSMETIC API MARKET, FOR MEA, BY APPLICATION, 2019-2035 (USD MILLION) 94 TABLE 86 PEPTIDE COSMETIC API MARKET, FOR MEA, BY SOURCE, 2019-2035 (USD MILLION) 94 TABLE 87 PEPTIDE COSMETIC API MARKET, FOR MEA, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 95 TABLE 88 GCC COUNTRIES: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 95 TABLE 89 GCC COUNTRIES: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 95 TABLE 90 GCC COUNTRIES: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 96 TABLE 91 SOUTH AFRICA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 96 TABLE 92 SOUTH AFRICA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 96 TABLE 93 SOUTH AFRICA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 97 TABLE 94 REST OF MEA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 97 TABLE 95 REST OF MEA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION) 97 TABLE 96 REST OF MEA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION) 98 TABLE 97 DSM-FIRMENICH: PRODUCT OFFERED 103 TABLE 98 BACHEM: PRODUCT OFFERED 108 TABLE 99 LIPOTRUE SCIENCE: PRODUCT OFFERED 111 TABLE 100 CRODA: PRODUCT OFFERED 115 TABLE 101 CAREGEN: PRODUCT OFFERED 118 TABLE 102 BASF SE: PRODUCT OFFERED 122 TABLE 103 EVONIK INDUSTRIES AG: PRODUCT OFFERED 126 TABLE 104 GIVAUDAN ACTIVE BEAUTY: PRODUCT OFFERED 130 TABLE 105 ASHLAND GLOBAL HOLDINGS: PRODUCT OFFERED 134 TABLE 106 SYMRISE AG: PRODUCT OFFERED 137 TABLE 107 PROVITAL GROUP: PRODUCT OFFERED 139 TABLE 108 SPEC-CHEM INDUSTRY INC: PRODUCT OFFERED 142 TABLE 109 AMBIOPHARM: PRODUCT OFFERED 145 TABLE 110 LIPOTEC: PRODUCT OFFERED 148 TABLE 111 USV PRIVATE LIMITED: PRODUCT OFFERED 151 TABLE 112 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR): PRODUCT OFFERED 154 TABLE 113 ACTIVE PEPTIDE COMPANY: PRODUCT OFFERED 157 TABLE 114 SEIWA KASEI CO., LTD: PRODUCT OFFERED 160 TABLE 115 RS SYNTHESIS: PRODUCT OFFERED 163 TABLE 116 BCN PEPTIDES: PRODUCT OFFERED 166 LIST OF FIGURES FIGURE 1 PEPTIDE COSMETIC API MARKET: MARKET GROWTH FACTOR ANALYSIS (2019-2035) 41 FIGURE 3 SUPPLY CHAIN ANALYSIS: PEPTIDE COSMETIC API MARKET 52 FIGURE 5 PORTER’S FIVE FORCES MODEL: PEPTIDE COSMETIC API MARKET 55 FIGURE 6 PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2023 (% SHARE) 61 FIGURE 7 PEPTIDE COSMETIC API MARKET, BY SOURCE, 2023 (% SHARE) 63 FIGURE 8 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2023 (% SHARE) 65 FIGURE 9 GLOBAL PEPTIDE COSMETIC API MARKET PLAYERS: COMPETITIVE ANALSIS, 2023 99 FIGURE 10 INDUSTRY CONCENTRATION, 2024 100 FIGURE 11 COMPETITOR DASHBOARD: GLOBAL MILITARY DRIVER VISION ENHANCER 101 FIGURE 12 DSM-FIRMENICH: FINANCIAL OVERVIEW SNAPSHOT 103 FIGURE 13 DSM-FIRMENICH: SWOT ANALYSIS 105 FIGURE 14 BACHEM: FINANCIAL OVERVIEW SNAPSHOT 108 FIGURE 15 BACHEM: SWOT ANALYSIS 110 FIGURE 16 LIPOTRUE SCIENCE: SWOT ANALYSIS 113 FIGURE 17 CRODA: FINANCIAL OVERVIEW SNAPSHOT 115 FIGURE 18 CRODA: SWOT ANALYSIS 117 FIGURE 19 CAREGEN: SWOT ANALYSIS 120 FIGURE 20 BASF SE: FINANCIAL OVERVIEW SNAPSHOT 121 FIGURE 21 BASF SE: SWOT ANALYSIS 123 FIGURE 22 EVONIK: FINANCIAL OVERVIEW SNAPSHOT 126 FIGURE 23 EVONIK INDUSTRIES AG: SWOT ANALYSIS 128 FIGURE 24 GIVAUDAN ACTIVE BEAUTY: FINANCIAL OVERVIEW SNAPSHOT 129 FIGURE 25 GIVAUDAN ACTIVE BEAUTY: SWOT ANALYSIS 131 FIGURE 26 ASHLAND GLOBAL HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT 133 FIGURE 27 ASHLAND GLOBAL HOLDINGS: SWOT ANALYSIS 135 FIGURE 28 SYMRISE AG: FINANCIAL OVERVIEW SNAPSHOT 136 FIGURE 29 SYMRISE AG: SWOT ANALYSIS 138 FIGURE 30 PROVITAL GROUP: SWOT ANALYSIS 141 FIGURE 31 SPEC-CHEM INDUSTRY INC: SWOT ANALYSIS 144 FIGURE 32 AMBIOPHARM: SWOT ANALYSIS 147 FIGURE 33 LIPOTEC: SWOT ANALYSIS 150 FIGURE 34 USV PRIVATE LIMITED: SWOT ANALYSIS 153 FIGURE 35 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR): SWOT ANALYSIS 156 FIGURE 36 ACTIVE PEPTIDE COMPANY: SWOT ANALYSIS 159 FIGURE 37 SEIWA KASEI CO., LTD: SWOT ANALYSIS 162 FIGURE 38 RS SYNTHESIS: SWOT ANALYSIS 165 FIGURE 39 BCN PEPTIDES: SWOT ANALYSIS 168

提及公司

DSM-FirmenichBachemLipotrue ScienceCrodaCaregenBASF SEEvonik Industries AGGivaudan Active BeautyAshland Global HoldingsSymrise AGProvital GroupSpec-Chem Industry IncAmbiopharmLipotecUSV Private LimitedChemisches Laboratorium Dr. Kurt Richter GmbHActive Peptide CompanySeiwa Kasei Co. Ltd.RS SynthesisBCN Peptides

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們